Safety and efficacy of Holmium laser enucleation of the prostate (HoLEP) in patients with previous transperineal biopsy (TPB): outcomes from a dual-centre case-control study.
BMC Urol
; 19(1): 97, 2019 Oct 22.
Article
en En
| MEDLINE
| ID: mdl-31640663
ABSTRACT
BACKGROUND:
We investigated the surgical feasibility, safety and effectiveness of 50 W (low power) Holmium Laser enucleation of the prostate (HoLEP) in patients who have undergone previous template biopsy of the prostate (TPB).METHODS:
Data encompassing pre-operative baseline characteristics, intra-operative measures and post-operative outcomes was collected for 109 patients undergoing HoLEP across two UK centres. Patients were stratified into two groups; group 1 (n = 24) had undergone previous TPB were compared with 'controls' (no previous TPB) in group 2 (n = 85). The primary outcome was successful HoLEP.RESULTS:
There were no statistically significant differences in either key baseline characteristics or mass of prostate enucleated between groups 1 and 2. There was no statistically significant difference in enucleation or morcellation times parameters between the two groups other than enucleation efficiency in favour of group 1 (p = 0.024). Functional outcomes improved, without any statistically significant difference, in both groups.CONCLUSIONS:
In patients with a previous TPB, HoLEP is surgically feasible, safe and effective. TPB should not be considered a contraindication to HoLEP. Our work provides a strong foundation for further research in this area.Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Próstata
/
Prostatectomía
/
Neoplasias de la Próstata
/
Láseres de Estado Sólido
Tipo de estudio:
Clinical_trials
/
Observational_studies
Idioma:
En
Revista:
BMC Urol
Asunto de la revista:
UROLOGIA
Año:
2019
Tipo del documento:
Article